Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nanjing Revamps Medical Trust For Centralized Drug Supply

This article was originally published in PharmAsia News

Executive Summary

Nanjing's push for medical trust, which started two years ago, will involve nine third-tier hospitals this May. Under the trust system, health care organizations entrust their pharmacy supply directly to pharmaceutical enterprises to cut expenses. According to statistics from the authorities, drug payment for patients decreased by 10 percent after second-tier hospitals participated in medical trust. Nanjing has established a medical trust center to manage medicine purchasing, drug income and expenses on behalf of nine hospitals. Its specialized central account allows unified billing with drug suppliers, increasing both parties' trust and reducing transaction costs. Analysts say the move represents the government's practical stop-gap approach to address insufficient funding for public hospitals. (Click her for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel